Shield Therapeutics Plc (STX):企業の財務・戦略的SWOT分析

◆英語タイトル:Shield Therapeutics Plc (STX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14782
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥41,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥82,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥124,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non-salt, oral formulation of ferric iron-based pharmaceutical product used to treat iron deficiency anaemia (IDA). Shield Therapeutics provides PT20, an iron-based phosphate binder, developed to treat hyperphosphatemia related to dialysis-dependent or dialysis-independent chronic kidney disease (CKD). The company operates has operations in the UK, Germany and Switzerland. Shield Therapeutics is headquartered in Gateshead, the UK.

Shield Therapeutics Plc Key Recent Developments

Jan 22,2019: Shield Therapeutics names James Karis as non-executive Chairman
Sep 19,2018: Shield Therapeutics announces interim report for the six months ended 30 June 2018
Sep 13,2018: 13 Sep 2018 Shield reports completion of recruitment to AEGIS Head to Head Study. Shield Therapeutics plc, today announces completion of recruitment of the AEGIS–H2H Phase 3b study of oral Feraccru compared to Intravenous (IV) ferric carboxymaltose in sub
Jul 26,2018: Shield Therapeutics Announces Appointment of Non-Executive Director

This comprehensive SWOT profile of Shield Therapeutics Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shield Therapeutics Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Shield Therapeutics Plc – Key Information
Shield Therapeutics Plc – Overview
Shield Therapeutics Plc – Key Employees
Shield Therapeutics Plc – Key Employee Biographies
Shield Therapeutics Plc – Key Operational Heads
Shield Therapeutics Plc – Major Products and Services
Shield Therapeutics Plc – History
Shield Therapeutics Plc – Company Statement
Shield Therapeutics Plc – Locations And Subsidiaries
Shield Therapeutics Plc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Shield Therapeutics Plc – Business Description
Shield Therapeutics Plc – Corporate Strategy
Shield Therapeutics Plc – SWOT Analysis
SWOT Analysis – Overview
Shield Therapeutics Plc – Strengths
Shield Therapeutics Plc – Weaknesses
Shield Therapeutics Plc – Opportunities
Shield Therapeutics Plc – Threats
Shield Therapeutics Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Shield Therapeutics Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Shield Therapeutics Plc, Key Information
Shield Therapeutics Plc, Key Ratios
Shield Therapeutics Plc, Share Data
Shield Therapeutics Plc, Major Products and Services
Shield Therapeutics Plc, History
Shield Therapeutics Plc, Key Employees
Shield Therapeutics Plc, Key Employee Biographies
Shield Therapeutics Plc, Key Operational Heads
Shield Therapeutics Plc, Other Locations
Shield Therapeutics Plc, Subsidiaries
Shield Therapeutics Plc, Key Manufacturing facilities
Shield Therapeutics Plc, Key Competitors
Shield Therapeutics Plc, SWOT Analysis
Shield Therapeutics Plc, Ratios based on current share price
Shield Therapeutics Plc, Annual Ratios
Shield Therapeutics Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Shield Therapeutics Plc, Performance Chart
Shield Therapeutics Plc, Ratio Charts

★海外企業調査レポート[Shield Therapeutics Plc (STX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brasfield & Gorrie LLC:企業の戦略・SWOT・財務情報
    Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report Summary Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Spire Inc (SR):企業の財務・戦略的SWOT分析
    Spire Inc (SR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Sanford Health:医療機器:M&Aディール及び事業提携情報
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center provides medical services in the areas of allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding d …
  • Koc Holding AS:企業の戦略・SWOT・財務分析
    Koc Holding AS - Strategy, SWOT and Corporate Finance Report Summary Koc Holding AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Bet Shemesh Engines Holdings (1997) Ltd:企業の戦略・SWOT・財務分析
    Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report Summary Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Bentley Systems Incorporated:企業のM&A・事業提携・投資動向
    Bentley Systems Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bentley Systems Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Louisiana-Pacific Corporation:戦略・SWOT・企業財務分析
    Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report Summary Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Stellar Resources Ltd:企業の戦略・SWOT・財務分析
    Stellar Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Stellar Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • BaroFold Inc-製薬・医療分野:企業M&A・提携分析
    Summary BaroFold Inc (BaroFold) is a biotechnology company that provides protein refolding services. The company offers services such as research study services, optimization study services, and process implementation services. Its optimization study services include confirm analytical services, res …
  • Consumers Energy Co:企業の発電所・SWOT分析2018
    Consumers Energy Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Datang International Power Generation Co Ltd:発電所・企業SWOT分析
    Datang International Power Generation Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Micropos Medical AB (MPOS):医療機器:M&Aディール及び事業提携情報
    Summary Micropos Medical AB (Micropos Medical) is a medical device company. The company develops technologies that enhance the precision in radiotherapy of cancer including hypofractionation and stereotactic radio surgery (SRS) and stereotactic body radiotherapy (SBRT). Its products include RayPilot …
  • China Resources Zizhu Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Zizhu Pharmaceutical Co Ltd (Zizhu Pharmaceutical) is a provider of pharmaceutical development, manufacture, and marketing programs. The company offers dietary supplements, women healthcare products, ophthalmology medicines, APIs and intermediates, anesthetic, biological agen …
  • Kadimastem Ltd (KDST):企業の財務・戦略的SWOT分析
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • Omron Healthcare Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Omron Healthcare Co Ltd (Omron Healthcare), a subsidiary of Omron Corp, is a provider of medical equipment for health monitoring and therapy. The company offers blood pressure monitors, digital thermometers, body fat meters, pedometers, nebulizers, body composition monitors and electric toot …
  • Chevalier International Holdings Ltd:企業の戦略・SWOT・財務情報
    Chevalier International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Chevalier International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • University of Texas MD Anderson Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Ander …
  • IDBI Bank Ltd:企業の戦略・SWOT・財務情報
    IDBI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary IDBI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Evotec AG (EVT)-医療機器分野:企業M&A・提携分析
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆